99mtc
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 31, 2009 (NCT02134613)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 99-technetium
Oral
No
Parenteral
No
Topical
No
Sources
- NCATS2JR2CU14D2 ↗
Also known as
- 99mtc
- 99mtc
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02514187 | N/A | Oct 1, 2015 | British Columbia Cancer Agency, Canadian Institutes of Health Research (CIHR), Centre for Probe Development and Commercialization, Natural Resources, Canada, University of Western Ontario |
| NCT02134613 | Phase 2 | Jan 31, 2009 | Federal University of Rio de Janeiro |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| British Columbia Cancer Agency | Academic/Hospital | 1 | 1 | 1 | 2015 |
| Canadian Institutes of Health Research (CIHR) | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Centre for Probe Development and Commercialization | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Federal University of Rio de Janeiro | Academic/Hospital | 1 | 1 | 1 | 2009 |
| Natural Resources, Canada | Academic/Hospital | 1 | 0 | 1 | 2015 |
| University of Western Ontario | Academic/Hospital | 1 | 0 | 1 | 2015 |
6 organizations
Page 1 / 1